Evidence map›Paper›PMID 31493123›Full record

Trial reportJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2020

CABANA trial: "beauty is in the eye of the beholder".

David Briceno, Prasant Mohanty, Luigi Di Biase, Jorge Romero, Domenico Giovanni Della Rocca, Chintan Trivedi, Sanghamitra Mohanty, Andrea Natale

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Stroke and mortality risk after atrial fibrillation ablation: lesson from the CABANA trial.European heart journal supplements : journal of the European Society of Cardiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

David BricenoMontefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th St. Bronx, New York, NY, 10467, USA.
Prasant MohantyTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, 78705, USA.
Luigi Di BiaseMontefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th St. Bronx, New York, NY, 10467, USA. dibbia@gmail.com.ORCID http://orcid.org/0000-0001-6508-4047
Jorge RomeroMontefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th St. Bronx, New York, NY, 10467, USA.
Domenico Giovanni Della RoccaTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, 78705, USA.
Chintan TrivediTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, 78705, USA.
Sanghamitra MohantyTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, 78705, USA.
Andrea NataleTexas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX, 78705, USA.
St David's Medical Center · USAlbert Einstein College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CABANA trial reported that catheter ablation, when compared with drug therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest in patients with atrial fibrillation. Despite multiple limitations in study design, the CABANA trial still confirmed that catheter ablation of atrial fibrillation led to clinically important and significant improvements in quality of life at 12 months without increasing the risk of complications.

Indexed as

Catheter AblationQuality of LifeAgedAnti-Arrhythmia AgentsAtrial FibrillationFemaleHeart ArrestHemorrhageHumansMaleMiddle AgedRecurrenceStrokeAnti-Arrhythmia AgentsAblationAtrila fibrillationMortalityOutcomes

Identifiers

PMID31493123
OpenAlexW2971446485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.